{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-126640","form_type":"8-K","ticker":"ACRS","cik":"0001557746","company_name":"Aclaris Therapeutics, Inc.","filed_at":"2022-12-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.140043+00:00","generated_at":"2026-06-21T05:23:43.718852+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Aclaris Therapeutics enters separation agreement with retiring executive Frank Ruffo","bullets":["Frank Ruffo's retirement separation agreement approved; includes consulting deal through March 2, 2023 for $25,000.","Ruffo will continue vesting of outstanding options and RSUs during the consulting period.","Exercise period for vested options extended to December 31, 2023.","Ruffo retains eligibility for 2022 annual bonus and accrued pay/vacation."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-126640","json":"https://secwatch.observer/filing/0001104659-22-126640.json","markdown":"https://secwatch.observer/filing/0001104659-22-126640.md","text":"https://secwatch.observer/filing/0001104659-22-126640.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1557746/000110465922126640/0001104659-22-126640-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1557746/000110465922126640/tm2232516d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T05:23:43.718852+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8f605fe6e2","claim":"Frank Ruffo retired as other_named_officer at Aclaris Therapeutics, Inc..","evidence_excerpt":"In connection with Mr. Ruffo’s previously announced retirement, on December 9, 2022, Aclaris Therapeutics, Inc. (the “ Company ”) and Mr. Ruffo entered into a Separation Agreement and General Release","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1557746/000110465922126640/0001104659-22-126640-index.htm","confidence":0.85,"family_label":"Executive change","details":[{"label":"Action","value":"retired"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}